Global Opioids Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Opioids market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 14810 million by 2030 with a CAGR of 5.3% during review period.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Opioids industry chain, the market status of Pain Relief (Oxycodone, Hydromorphone), Anesthesia (Oxycodone, Hydromorphone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioids.
Regionally, the report analyzes the Opioids markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioids market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Opioids market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Opioids industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Oxycodone, Hydromorphone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Opioids market.
Regional Analysis: The report involves examining the Opioids market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Opioids market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Opioids:
Company Analysis: Report covers individual Opioids manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Opioids This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pain Relief, Anesthesia).
Technology Analysis: Report covers specific technologies relevant to Opioids. It assesses the current state, advancements, and potential future developments in Opioids areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Opioids market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Opioids market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Opioids product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids, with price, sales, revenue and global market share of Opioids from 2019 to 2024.
Chapter 3, the Opioids competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Opioids market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids.
Chapter 14 and 15, to describe Opioids sales channel, distributors, customers, research findings and conclusion.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Opioids industry chain, the market status of Pain Relief (Oxycodone, Hydromorphone), Anesthesia (Oxycodone, Hydromorphone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioids.
Regionally, the report analyzes the Opioids markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioids market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Opioids market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Opioids industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Oxycodone, Hydromorphone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Opioids market.
Regional Analysis: The report involves examining the Opioids market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Opioids market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Opioids:
Company Analysis: Report covers individual Opioids manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Opioids This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pain Relief, Anesthesia).
Technology Analysis: Report covers specific technologies relevant to Opioids. It assesses the current state, advancements, and potential future developments in Opioids areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Opioids market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Opioids market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Other
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- Deaddiction
- Others
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Opioids product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids, with price, sales, revenue and global market share of Opioids from 2019 to 2024.
Chapter 3, the Opioids competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Opioids market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids.
Chapter 14 and 15, to describe Opioids sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Opioids
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioids Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oxycodone
1.3.3 Hydromorphone
1.3.4 Codeine
1.3.5 Fentanyl
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioids Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pain Relief
1.4.3 Anesthesia
1.4.4 Cough Suppression
1.4.5 Diarrhea Suppression
1.4.6 Deaddiction
1.4.7 Others
1.5 Global Opioids Market Size & Forecast
1.5.1 Global Opioids Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Opioids Sales Quantity (2019-2030)
1.5.3 Global Opioids Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Product and Services
2.1.4 Teva Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Teva Recent Developments/Updates
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Product and Services
2.2.4 Purdue Pharma Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Purdue Pharma Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Product and Services
2.3.4 Mallinckrodt Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Product and Services
2.4.4 Amneal Pharma Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amneal Pharma Recent Developments/Updates
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Product and Services
2.5.4 Collegium Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Collegium Recent Developments/Updates
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Product and Services
2.6.4 J&J Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 J&J Recent Developments/Updates
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Product and Services
2.7.4 Endo Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Endo Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Product and Services
2.8.4 Pfizer Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Product and Services
2.9.4 INSYS Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 INSYS Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Product and Services
2.10.4 Mylan Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mylan Recent Developments/Updates
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Product and Services
2.11.4 Hikma Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hikma Recent Developments/Updates
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Product and Services
2.12.4 Egalet Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Egalet Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOIDS BY MANUFACTURER
3.1 Global Opioids Sales Quantity by Manufacturer (2019-2024)
3.2 Global Opioids Revenue by Manufacturer (2019-2024)
3.3 Global Opioids Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Opioids by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Opioids Manufacturer Market Share in 2023
3.4.2 Top 6 Opioids Manufacturer Market Share in 2023
3.5 Opioids Market: Overall Company Footprint Analysis
3.5.1 Opioids Market: Region Footprint
3.5.2 Opioids Market: Company Product Type Footprint
3.5.3 Opioids Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioids Market Size by Region
4.1.1 Global Opioids Sales Quantity by Region (2019-2030)
4.1.2 Global Opioids Consumption Value by Region (2019-2030)
4.1.3 Global Opioids Average Price by Region (2019-2030)
4.2 North America Opioids Consumption Value (2019-2030)
4.3 Europe Opioids Consumption Value (2019-2030)
4.4 Asia-Pacific Opioids Consumption Value (2019-2030)
4.5 South America Opioids Consumption Value (2019-2030)
4.6 Middle East and Africa Opioids Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioids Sales Quantity by Type (2019-2030)
5.2 Global Opioids Consumption Value by Type (2019-2030)
5.3 Global Opioids Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioids Sales Quantity by Application (2019-2030)
6.2 Global Opioids Consumption Value by Application (2019-2030)
6.3 Global Opioids Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Opioids Sales Quantity by Type (2019-2030)
7.2 North America Opioids Sales Quantity by Application (2019-2030)
7.3 North America Opioids Market Size by Country
7.3.1 North America Opioids Sales Quantity by Country (2019-2030)
7.3.2 North America Opioids Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Opioids Sales Quantity by Type (2019-2030)
8.2 Europe Opioids Sales Quantity by Application (2019-2030)
8.3 Europe Opioids Market Size by Country
8.3.1 Europe Opioids Sales Quantity by Country (2019-2030)
8.3.2 Europe Opioids Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioids Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Opioids Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Opioids Market Size by Region
9.3.1 Asia-Pacific Opioids Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Opioids Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Opioids Sales Quantity by Type (2019-2030)
10.2 South America Opioids Sales Quantity by Application (2019-2030)
10.3 South America Opioids Market Size by Country
10.3.1 South America Opioids Sales Quantity by Country (2019-2030)
10.3.2 South America Opioids Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioids Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Opioids Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Opioids Market Size by Country
11.3.1 Middle East & Africa Opioids Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Opioids Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Opioids Market Drivers
12.2 Opioids Market Restraints
12.3 Opioids Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioids and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioids
13.3 Opioids Production Process
13.4 Opioids Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioids Typical Distributors
14.3 Opioids Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Opioids
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioids Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oxycodone
1.3.3 Hydromorphone
1.3.4 Codeine
1.3.5 Fentanyl
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioids Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pain Relief
1.4.3 Anesthesia
1.4.4 Cough Suppression
1.4.5 Diarrhea Suppression
1.4.6 Deaddiction
1.4.7 Others
1.5 Global Opioids Market Size & Forecast
1.5.1 Global Opioids Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Opioids Sales Quantity (2019-2030)
1.5.3 Global Opioids Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Product and Services
2.1.4 Teva Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Teva Recent Developments/Updates
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Product and Services
2.2.4 Purdue Pharma Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Purdue Pharma Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Product and Services
2.3.4 Mallinckrodt Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Product and Services
2.4.4 Amneal Pharma Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amneal Pharma Recent Developments/Updates
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Product and Services
2.5.4 Collegium Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Collegium Recent Developments/Updates
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Product and Services
2.6.4 J&J Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 J&J Recent Developments/Updates
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Product and Services
2.7.4 Endo Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Endo Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Product and Services
2.8.4 Pfizer Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Product and Services
2.9.4 INSYS Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 INSYS Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Product and Services
2.10.4 Mylan Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mylan Recent Developments/Updates
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Product and Services
2.11.4 Hikma Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hikma Recent Developments/Updates
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Product and Services
2.12.4 Egalet Opioids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Egalet Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOIDS BY MANUFACTURER
3.1 Global Opioids Sales Quantity by Manufacturer (2019-2024)
3.2 Global Opioids Revenue by Manufacturer (2019-2024)
3.3 Global Opioids Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Opioids by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Opioids Manufacturer Market Share in 2023
3.4.2 Top 6 Opioids Manufacturer Market Share in 2023
3.5 Opioids Market: Overall Company Footprint Analysis
3.5.1 Opioids Market: Region Footprint
3.5.2 Opioids Market: Company Product Type Footprint
3.5.3 Opioids Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioids Market Size by Region
4.1.1 Global Opioids Sales Quantity by Region (2019-2030)
4.1.2 Global Opioids Consumption Value by Region (2019-2030)
4.1.3 Global Opioids Average Price by Region (2019-2030)
4.2 North America Opioids Consumption Value (2019-2030)
4.3 Europe Opioids Consumption Value (2019-2030)
4.4 Asia-Pacific Opioids Consumption Value (2019-2030)
4.5 South America Opioids Consumption Value (2019-2030)
4.6 Middle East and Africa Opioids Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioids Sales Quantity by Type (2019-2030)
5.2 Global Opioids Consumption Value by Type (2019-2030)
5.3 Global Opioids Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioids Sales Quantity by Application (2019-2030)
6.2 Global Opioids Consumption Value by Application (2019-2030)
6.3 Global Opioids Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Opioids Sales Quantity by Type (2019-2030)
7.2 North America Opioids Sales Quantity by Application (2019-2030)
7.3 North America Opioids Market Size by Country
7.3.1 North America Opioids Sales Quantity by Country (2019-2030)
7.3.2 North America Opioids Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Opioids Sales Quantity by Type (2019-2030)
8.2 Europe Opioids Sales Quantity by Application (2019-2030)
8.3 Europe Opioids Market Size by Country
8.3.1 Europe Opioids Sales Quantity by Country (2019-2030)
8.3.2 Europe Opioids Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioids Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Opioids Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Opioids Market Size by Region
9.3.1 Asia-Pacific Opioids Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Opioids Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Opioids Sales Quantity by Type (2019-2030)
10.2 South America Opioids Sales Quantity by Application (2019-2030)
10.3 South America Opioids Market Size by Country
10.3.1 South America Opioids Sales Quantity by Country (2019-2030)
10.3.2 South America Opioids Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioids Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Opioids Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Opioids Market Size by Country
11.3.1 Middle East & Africa Opioids Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Opioids Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Opioids Market Drivers
12.2 Opioids Market Restraints
12.3 Opioids Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioids and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioids
13.3 Opioids Production Process
13.4 Opioids Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioids Typical Distributors
14.3 Opioids Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioids Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Opioids Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Product and Services
Table 6. Teva Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Teva Recent Developments/Updates
Table 8. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Purdue Pharma Major Business
Table 10. Purdue Pharma Opioids Product and Services
Table 11. Purdue Pharma Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Purdue Pharma Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Opioids Product and Services
Table 16. Mallinckrodt Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Amneal Pharma Major Business
Table 20. Amneal Pharma Opioids Product and Services
Table 21. Amneal Pharma Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Amneal Pharma Recent Developments/Updates
Table 23. Collegium Basic Information, Manufacturing Base and Competitors
Table 24. Collegium Major Business
Table 25. Collegium Opioids Product and Services
Table 26. Collegium Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Collegium Recent Developments/Updates
Table 28. J&J Basic Information, Manufacturing Base and Competitors
Table 29. J&J Major Business
Table 30. J&J Opioids Product and Services
Table 31. J&J Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. J&J Recent Developments/Updates
Table 33. Endo Basic Information, Manufacturing Base and Competitors
Table 34. Endo Major Business
Table 35. Endo Opioids Product and Services
Table 36. Endo Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Endo Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Opioids Product and Services
Table 41. Pfizer Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Pfizer Recent Developments/Updates
Table 43. INSYS Basic Information, Manufacturing Base and Competitors
Table 44. INSYS Major Business
Table 45. INSYS Opioids Product and Services
Table 46. INSYS Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. INSYS Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Opioids Product and Services
Table 51. Mylan Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Mylan Recent Developments/Updates
Table 53. Hikma Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Major Business
Table 55. Hikma Opioids Product and Services
Table 56. Hikma Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hikma Recent Developments/Updates
Table 58. Egalet Basic Information, Manufacturing Base and Competitors
Table 59. Egalet Major Business
Table 60. Egalet Opioids Product and Services
Table 61. Egalet Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Egalet Recent Developments/Updates
Table 63. Global Opioids Sales Quantity by Manufacturer (2019-2024) & (MT)
Table 64. Global Opioids Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Opioids Average Price by Manufacturer (2019-2024) & (USD/Kg)
Table 66. Market Position of Manufacturers in Opioids, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Opioids Production Site of Key Manufacturer
Table 68. Opioids Market: Company Product Type Footprint
Table 69. Opioids Market: Company Product Application Footprint
Table 70. Opioids New Market Entrants and Barriers to Market Entry
Table 71. Opioids Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Opioids Sales Quantity by Region (2019-2024) & (MT)
Table 73. Global Opioids Sales Quantity by Region (2025-2030) & (MT)
Table 74. Global Opioids Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Opioids Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Opioids Average Price by Region (2019-2024) & (USD/Kg)
Table 77. Global Opioids Average Price by Region (2025-2030) & (USD/Kg)
Table 78. Global Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 79. Global Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 80. Global Opioids Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Opioids Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Opioids Average Price by Type (2019-2024) & (USD/Kg)
Table 83. Global Opioids Average Price by Type (2025-2030) & (USD/Kg)
Table 84. Global Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 85. Global Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 86. Global Opioids Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Opioids Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Opioids Average Price by Application (2019-2024) & (USD/Kg)
Table 89. Global Opioids Average Price by Application (2025-2030) & (USD/Kg)
Table 90. North America Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 91. North America Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 92. North America Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 93. North America Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 94. North America Opioids Sales Quantity by Country (2019-2024) & (MT)
Table 95. North America Opioids Sales Quantity by Country (2025-2030) & (MT)
Table 96. North America Opioids Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Opioids Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 99. Europe Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 100. Europe Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 101. Europe Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 102. Europe Opioids Sales Quantity by Country (2019-2024) & (MT)
Table 103. Europe Opioids Sales Quantity by Country (2025-2030) & (MT)
Table 104. Europe Opioids Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Opioids Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 107. Asia-Pacific Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 108. Asia-Pacific Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 109. Asia-Pacific Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 110. Asia-Pacific Opioids Sales Quantity by Region (2019-2024) & (MT)
Table 111. Asia-Pacific Opioids Sales Quantity by Region (2025-2030) & (MT)
Table 112. Asia-Pacific Opioids Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Opioids Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 115. South America Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 116. South America Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 117. South America Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 118. South America Opioids Sales Quantity by Country (2019-2024) & (MT)
Table 119. South America Opioids Sales Quantity by Country (2025-2030) & (MT)
Table 120. South America Opioids Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Opioids Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 123. Middle East & Africa Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 124. Middle East & Africa Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 125. Middle East & Africa Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 126. Middle East & Africa Opioids Sales Quantity by Region (2019-2024) & (MT)
Table 127. Middle East & Africa Opioids Sales Quantity by Region (2025-2030) & (MT)
Table 128. Middle East & Africa Opioids Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Opioids Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Opioids Raw Material
Table 131. Key Manufacturers of Opioids Raw Materials
Table 132. Opioids Typical Distributors
Table 133. Opioids Typical Customers
Table 1. Global Opioids Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Opioids Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Product and Services
Table 6. Teva Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Teva Recent Developments/Updates
Table 8. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Purdue Pharma Major Business
Table 10. Purdue Pharma Opioids Product and Services
Table 11. Purdue Pharma Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Purdue Pharma Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Opioids Product and Services
Table 16. Mallinckrodt Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Amneal Pharma Major Business
Table 20. Amneal Pharma Opioids Product and Services
Table 21. Amneal Pharma Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Amneal Pharma Recent Developments/Updates
Table 23. Collegium Basic Information, Manufacturing Base and Competitors
Table 24. Collegium Major Business
Table 25. Collegium Opioids Product and Services
Table 26. Collegium Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Collegium Recent Developments/Updates
Table 28. J&J Basic Information, Manufacturing Base and Competitors
Table 29. J&J Major Business
Table 30. J&J Opioids Product and Services
Table 31. J&J Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. J&J Recent Developments/Updates
Table 33. Endo Basic Information, Manufacturing Base and Competitors
Table 34. Endo Major Business
Table 35. Endo Opioids Product and Services
Table 36. Endo Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Endo Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Opioids Product and Services
Table 41. Pfizer Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Pfizer Recent Developments/Updates
Table 43. INSYS Basic Information, Manufacturing Base and Competitors
Table 44. INSYS Major Business
Table 45. INSYS Opioids Product and Services
Table 46. INSYS Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. INSYS Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Opioids Product and Services
Table 51. Mylan Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Mylan Recent Developments/Updates
Table 53. Hikma Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Major Business
Table 55. Hikma Opioids Product and Services
Table 56. Hikma Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hikma Recent Developments/Updates
Table 58. Egalet Basic Information, Manufacturing Base and Competitors
Table 59. Egalet Major Business
Table 60. Egalet Opioids Product and Services
Table 61. Egalet Opioids Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Egalet Recent Developments/Updates
Table 63. Global Opioids Sales Quantity by Manufacturer (2019-2024) & (MT)
Table 64. Global Opioids Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Opioids Average Price by Manufacturer (2019-2024) & (USD/Kg)
Table 66. Market Position of Manufacturers in Opioids, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Opioids Production Site of Key Manufacturer
Table 68. Opioids Market: Company Product Type Footprint
Table 69. Opioids Market: Company Product Application Footprint
Table 70. Opioids New Market Entrants and Barriers to Market Entry
Table 71. Opioids Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Opioids Sales Quantity by Region (2019-2024) & (MT)
Table 73. Global Opioids Sales Quantity by Region (2025-2030) & (MT)
Table 74. Global Opioids Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Opioids Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Opioids Average Price by Region (2019-2024) & (USD/Kg)
Table 77. Global Opioids Average Price by Region (2025-2030) & (USD/Kg)
Table 78. Global Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 79. Global Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 80. Global Opioids Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Opioids Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Opioids Average Price by Type (2019-2024) & (USD/Kg)
Table 83. Global Opioids Average Price by Type (2025-2030) & (USD/Kg)
Table 84. Global Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 85. Global Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 86. Global Opioids Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Opioids Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Opioids Average Price by Application (2019-2024) & (USD/Kg)
Table 89. Global Opioids Average Price by Application (2025-2030) & (USD/Kg)
Table 90. North America Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 91. North America Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 92. North America Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 93. North America Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 94. North America Opioids Sales Quantity by Country (2019-2024) & (MT)
Table 95. North America Opioids Sales Quantity by Country (2025-2030) & (MT)
Table 96. North America Opioids Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Opioids Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 99. Europe Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 100. Europe Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 101. Europe Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 102. Europe Opioids Sales Quantity by Country (2019-2024) & (MT)
Table 103. Europe Opioids Sales Quantity by Country (2025-2030) & (MT)
Table 104. Europe Opioids Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Opioids Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 107. Asia-Pacific Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 108. Asia-Pacific Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 109. Asia-Pacific Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 110. Asia-Pacific Opioids Sales Quantity by Region (2019-2024) & (MT)
Table 111. Asia-Pacific Opioids Sales Quantity by Region (2025-2030) & (MT)
Table 112. Asia-Pacific Opioids Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Opioids Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 115. South America Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 116. South America Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 117. South America Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 118. South America Opioids Sales Quantity by Country (2019-2024) & (MT)
Table 119. South America Opioids Sales Quantity by Country (2025-2030) & (MT)
Table 120. South America Opioids Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Opioids Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Opioids Sales Quantity by Type (2019-2024) & (MT)
Table 123. Middle East & Africa Opioids Sales Quantity by Type (2025-2030) & (MT)
Table 124. Middle East & Africa Opioids Sales Quantity by Application (2019-2024) & (MT)
Table 125. Middle East & Africa Opioids Sales Quantity by Application (2025-2030) & (MT)
Table 126. Middle East & Africa Opioids Sales Quantity by Region (2019-2024) & (MT)
Table 127. Middle East & Africa Opioids Sales Quantity by Region (2025-2030) & (MT)
Table 128. Middle East & Africa Opioids Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Opioids Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Opioids Raw Material
Table 131. Key Manufacturers of Opioids Raw Materials
Table 132. Opioids Typical Distributors
Table 133. Opioids Typical Customers
LIST OF FIGURES
Figure 1. Opioids Picture
Figure 2. Global Opioids Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Opioids Consumption Value Market Share by Type in 2023
Figure 4. Oxycodone Examples
Figure 5. Hydromorphone Examples
Figure 6. Codeine Examples
Figure 7. Fentanyl Examples
Figure 8. Other Examples
Figure 9. Global Opioids Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Opioids Consumption Value Market Share by Application in 2023
Figure 11. Pain Relief Examples
Figure 12. Anesthesia Examples
Figure 13. Cough Suppression Examples
Figure 14. Diarrhea Suppression Examples
Figure 15. Deaddiction Examples
Figure 16. Others Examples
Figure 17. Global Opioids Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Opioids Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Opioids Sales Quantity (2019-2030) & (MT)
Figure 20. Global Opioids Average Price (2019-2030) & (USD/Kg)
Figure 21. Global Opioids Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Opioids Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Opioids by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Opioids Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Opioids Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Opioids Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Opioids Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Opioids Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Opioids Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Opioids Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Opioids Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Opioids Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Opioids Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Opioids Average Price by Type (2019-2030) & (USD/Kg)
Figure 36. Global Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Opioids Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Opioids Average Price by Application (2019-2030) & (USD/Kg)
Figure 39. North America Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Opioids Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Opioids Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Opioids Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Opioids Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Opioids Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Opioids Consumption Value Market Share by Region (2019-2030)
Figure 59. China Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Opioids Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Opioids Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Opioids Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Opioids Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Opioids Market Drivers
Figure 80. Opioids Market Restraints
Figure 81. Opioids Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Opioids in 2023
Figure 84. Manufacturing Process Analysis of Opioids
Figure 85. Opioids Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. Opioids Picture
Figure 2. Global Opioids Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Opioids Consumption Value Market Share by Type in 2023
Figure 4. Oxycodone Examples
Figure 5. Hydromorphone Examples
Figure 6. Codeine Examples
Figure 7. Fentanyl Examples
Figure 8. Other Examples
Figure 9. Global Opioids Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Opioids Consumption Value Market Share by Application in 2023
Figure 11. Pain Relief Examples
Figure 12. Anesthesia Examples
Figure 13. Cough Suppression Examples
Figure 14. Diarrhea Suppression Examples
Figure 15. Deaddiction Examples
Figure 16. Others Examples
Figure 17. Global Opioids Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Opioids Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Opioids Sales Quantity (2019-2030) & (MT)
Figure 20. Global Opioids Average Price (2019-2030) & (USD/Kg)
Figure 21. Global Opioids Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Opioids Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Opioids by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Opioids Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Opioids Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Opioids Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Opioids Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Opioids Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Opioids Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Opioids Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Opioids Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Opioids Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Opioids Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Opioids Average Price by Type (2019-2030) & (USD/Kg)
Figure 36. Global Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Opioids Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Opioids Average Price by Application (2019-2030) & (USD/Kg)
Figure 39. North America Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Opioids Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Opioids Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Opioids Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Opioids Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Opioids Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Opioids Consumption Value Market Share by Region (2019-2030)
Figure 59. China Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Opioids Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Opioids Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Opioids Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Opioids Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Opioids Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Opioids Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Opioids Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Opioids Market Drivers
Figure 80. Opioids Market Restraints
Figure 81. Opioids Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Opioids in 2023
Figure 84. Manufacturing Process Analysis of Opioids
Figure 85. Opioids Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
